Glycogen, a hyperbranched polymer of glucose, plays a central role as an energy reserve across diverse organisms. In Escherichia coli, its biosynthesis is linked not only to energy storage but also to ...
Granules India, through a subsidiary, has received U.S. Food and Drug Administration’s (FDA’s) tentative approval for its generic of attention deficit hyperactivity disorder drug Adzenys-XR-ODT. The ...
https://www.thehindubusinessline.com/markets/stock-markets/granules-india-to-raise-176250-crore/article70428757.ece Copy The board of directors of Granules India ...
Granules India Board on Tuesday approved the drugmaker’s proposals to raise ₹1,762.50 crore through issue of preferential convertible warrants and equity shares. The company plans to issue 2.5 crore ...
Hosted on MSN
Granules unit gets USFDA nod for generic drug
New Delhi: Drug firm Granules India on Monday said it has received approval from the US health regulator to market a generic medication for attention deficit hyperactivity disorder. Granules ...
In brilliant collaboration, Carl and Gerty Cori studied how the body metabolizes glucose and advanced the understanding of how the body produces and stores energy. Their findings were particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback